LogicBio Therapeutics, Inc. - stock earnings
Stock symbol LOGC is outdated, potentially delisted? Maybe it is available on other exchange?
LOGC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | -5.0 million USD | 3.2 million USD |
| 2022Q1 | -6.7 million USD | 2.8 million USD |
| 2021Q4 | -9.1 million USD | 2.0 million USD |
| 2021Q3 | -10.2 million USD | 2.1 million USD |
| 2021Q2 | -10.5 million USD | 802000 USD |
| 2021Q1 | -10.3 million USD | 461000 USD |
| 2020Q4 | -6.9 million USD | 542000 USD |
| 2020Q3 | -8.0 million USD | 926000 USD |
LOGC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -40.0 million USD | 5.4 million USD |
| 2020 | -32.6 million USD | 3.5 million USD |
| 2019 | -40.1 million USD | ? USD |
| 2018 | -17.6 million USD | ? USD |
| 2017 | -5.8 million USD | ? USD |
LOGC
Price: $2.07
52 week price:
Earnings Per Share: -0.88 USD
P/E Ratio: -3.94
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 81270
Market Capitalization: 68.2 million